Literature DB >> 8056184

Inflammatory islet damage in patients bearing HLA-DR 3 and/or DR 4 haplotypes does not lead to islet autoimmunity.

E F Lampeter1, I Seifert, D Lohmann, J W Heise, J Bertrams, M R Christie, V Kolb-Bachofen, H Kolb.   

Abstract

The hypothesis was tested that islet autoimmunity is induced by ongoing islet cell destruction in subjects with susceptibility genes HLA-DR 3 and/or DR 4. Sixty-one patients with confirmed chronic pancreatitis were analysed, 30 of whom expressed HLA-DR 3 and/or DR 4. Electron microscopy studies in 10 patients showed that the inflammatory process also affected islets, as recognisable from islet cell lysis, intrainsular fibrosis and immune cell infiltrates. None of the sera tested contained any of three markers of islet autoimmunity, ICA, IAA or GAD antibodies. A correlation was seen between the loss of exocrine function, as determined by the ALTAB-test, and of beta-cell function, as determined by the C-peptide response to i.v. glucagon. However, there was no preferential loss of beta-cell function in patients with HLA-DR 3 and/or DR 4. We conclude that islet cell destruction occurs during chronic pancreatitis, but does not trigger islet autoimmunity, even in the presence of HLA-DR 3 and/or DR 4.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8056184     DOI: 10.1007/s001250050134

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  Insulin-dependent diabetes mellitus secondary to chronic pancreatitis is not associated with HLA or the occurrence of islet-cell antibodies.

Authors:  S Larsen; J Hilsted; B K Jakobsen; A Svejgaard; B Marner; H Worning
Journal:  J Immunogenet       Date:  1990-06

2.  The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies. The Immunology and Diabetes Workshops and Participating Laboratories.

Authors:  A Lernmark; J L Molenaar; W A van Beers; Y Yamaguchi; S Nagataki; J Ludvigsson; N K Maclaren
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

3.  Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement.

Authors:  C J Greenbaum; J P Palmer; B Kuglin; H Kolb
Journal:  J Clin Endocrinol Metab       Date:  1992-05       Impact factor: 5.958

4.  Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes.

Authors:  R Ziegler; C A Alper; Z L Awdeh; L Castano; S J Brink; J S Soeldner; R A Jackson; G S Eisenbarth
Journal:  Diabetes       Date:  1991-06       Impact factor: 9.461

5.  Differences in the natural history of idiopathic (nonalcoholic) and alcoholic chronic pancreatitis. A comparative long-term study of 287 patients.

Authors:  R W Ammann; H Buehler; R Muench; A W Freiburghaus; W Siegenthaler
Journal:  Pancreas       Date:  1987       Impact factor: 3.327

6.  HLA-associated insulin autoantibody formation in newly diagnosed type I diabetic patients.

Authors:  A G Ziegler; E Standl; E Albert; H Mehnert
Journal:  Diabetes       Date:  1991-09       Impact factor: 9.461

7.  Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination.

Authors:  K Helmke; A Otten; W R Willems; R Brockhaus; G Mueller-Eckhardt; T Stief; J Bertrams; H Wolf; K Federlin
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122

Review 8.  HLA and insulin-dependent diabetes. A protective perspective.

Authors:  M J Sheehy
Journal:  Diabetes       Date:  1992-02       Impact factor: 9.461

9.  Binding of antibodies in sera from Type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues. Evidence for antigenic and non-antigenic forms of the enzyme.

Authors:  M R Christie; T J Brown; D Cassidy
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

10.  Beta-cell reserve capacity in chronic pancreatitis.

Authors:  S Domschke; K P Stock; J Pichl; M U Schneider; W Domschke
Journal:  Hepatogastroenterology       Date:  1985-02
View more
  3 in total

1.  Evaluating the Immunopathogenesis of Diabetes After Acute Pancreatitis in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium.

Authors:  Anna Casu; Paul J Grippo; Clive Wasserfall; Zhaoli Sun; Peter S Linsley; Jessica A Hamerman; Brian T Fife; Adam Lacy-Hulbert; Frederico G S Toledo; Phil A Hart; Georgios I Papachristou; Melena D Bellin; Dhiraj Yadav; Maren R Laughlin; Mark O Goodarzi; Cate Speake
Journal:  Pancreas       Date:  2022-07-01       Impact factor: 3.243

Review 2.  Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?).

Authors:  Bart O Roep; Sofia Thomaidou; René van Tienhoven; Arnaud Zaldumbide
Journal:  Nat Rev Endocrinol       Date:  2020-12-08       Impact factor: 43.330

3.  β-Cells, autoimmunity, and the innate immune system: "un ménage á trois"?

Authors:  Bart O Roep
Journal:  Diabetes       Date:  2013-06       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.